Takeda Pharmaceutical (NYSE:TAK) Upgraded by Morgan Stanley to “Overweight” Rating
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) was upgraded by equities research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a note issued to investors on Wednesday, Marketbeat Ratings reports. Takeda Pharmaceutical Stock Up 1.4 % TAK stock opened at $15.19 on Wednesday. Takeda Pharmaceutical has a fifty-two week […]
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) was upgraded by equities research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a note issued to investors on Wednesday, Marketbeat Ratings reports. Takeda Pharmaceutical Stock Up 1.4 % TAK stock opened at $15.19 on Wednesday. Takeda Pharmaceutical has a fifty-two week […]
